Nurix Therapeutics, Inc.

NRIX

Nurix Therapeutics, Inc.

NRIX

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-25Shares Purchased (TTM):0Shares Sold (TTM):184,689

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:112,575,301Shares Outstanding:110,071,668Institutional Ownership Pct.:102.27%

Earnings Market Reaction:

Filing Date:2026-07-09Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-05-31	2026-02-28	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-11-30	2024-08-31	2024-05-31	2024-02-29	2023-11-30	2023-08-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	68	71	247	78	84	76	110	99	117	50	55	42
Marketable Securities Current	-	-	-	-	-	-	-	-	-	-	-	217
Debt Securities Available For Sale Amortized Cost …	-	-	-	-	-	-	-	-	-	194	233	-
Debt Securities Available For Sale Excluding Accru…	376	470	346	350	402	474	500	349	326	-	233	-
Accounts Receivable Net Current	-	-	-	-	19	-	-	-	-	-	-	2
Prepaid Expense And Other Assets Current	13	14	14	12	11	14	10	8	7	7	8	7
Assets Current	456	554	607	441	515	564	619	456	450	251	296	268
Marketable Securities Noncurrent	-	-	-	-	-	-	-	-	-	-	-	10
Debt Securities Available For Sale Amortized Cost …	-	-	-	-	-	-	-	-	-	10	7	-
Operating Lease Right Of Use Asset	50	52	51	53	50	26	28	27	29	29	31	9
Debt Securities Available For Sale Excluding Accru…	-	-	-	-	-	-	0	9	9	-	7	-
Property Plant And Equipment Net	20	22	22	20	19	18	18	17	19	18	17	17
Restricted Cash Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	8	7	7	7	6	6	3	3	3	3	4	4
Assets	536	636	688	522	592	615	669	514	511	313	356	308
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	12	10	11	9	6	8	11	4	3	6	6	2
Operating Lease Liability Current	3	3	3	4	5	7	8	7	8	7	7	5
Contract With Customer Liability Current	13	19	18	26	27	31	38	48	47	46	48	32
Liabilities Current	72	92	86	82	76	90	96	86	81	88	87	61
Operating Lease Liability Noncurrent	55	55	53	53	47	20	20	21	21	22	23	3
Contract With Customer Liability Noncurrent	6	8	10	15	22	24	26	30	39	34	45	10
Liabilities	133	155	149	150	144	134	142	137	140	144	155	74
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,583	1,571	1,542	1,297	1,286	1,276	1,266	1,057	1,002	756	746	738
Accumulated Other Comprehensive Income Loss Net Of…	-0	0	0	0	-0	0	0	0	-0	-0	-1	-1
Retained Earnings Accumulated Deficit	-1,180	-1,090	-1,003	-925	-839	-795	-739	-680	-631	-587	-545	-503
Stockholders Equity	403	481	539	372	448	481	527	377	371	169	200	234
Liabilities And Stockholders Equity	536	636	688	522	592	615	669	514	511	313	356	308
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	104	103	102	77	76	76	76	67	64	49	49	49
Shares Outstanding	104	103	102	77	76	76	76	67	64	49	49	49

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	7.76%	13.85%	46.79%	-5.99%	-	-	-	-	-	-	-	-
2025	21.71%	14.79%	25.70%	-16.24%	-29.14%	-32.25%	19.15%	62.80%	77.72%	-11.70%	-19.25%	-2.01%
2024	-18.55%	0.38%	33.01%	-5.67%	14.39%	4.63%	3.55%	-6.43%	-19.13%	-13.75%	-33.59%	-47.65%
2023	-	-	-	-4.46%	-14.19%	-22.02%	3.69%	10.91%	65.65%	50.76%	41.12%	29.75%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-05-31	2026-02-28	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-11-30	2024-08-31	2024-05-31	2024-02-29	2023-11-30	2023-08-31
Liquidity Ratios
Current Ratio	6.34	6.01	7.02	5.35	6.82	6.26	6.46	5.28	5.57	2.86	3.40	4.36
Quick Ratio	6.16	5.86	6.86	5.21	6.68	6.11	6.36	5.19	5.49	2.78	3.31	4.24
Working Capital	384.46M	462.20M	520.35M	358.25M	439.72M	473.72M	523.53M	369.75M	369.44M	163.35M	208.55M	206.46M
Leverage & Debt
Debt to Equity	0.33	0.32	0.28	0.40	0.32	0.28	0.27	0.36	0.38	0.85	0.77	0.32
Debt Ratio	0.25	0.24	0.22	0.29	0.24	0.22	0.21	0.27	0.27	0.46	0.44	0.24
Efficiency & Turnover
Asset Turnover TTM	0.07	0.11	0.12	0.16	0.16	0.12	0.11	0.14	0.14	0.24	0.20	0.18
Days Sales Outstanding TTM	-	-	-	-	78.47	-	-	-	-	-	-	10.64
Receivables Turnover TTM	-	-	-	-	4.65	-	-	-	-	-	-	34.31
Per Share Metrics
Diluted EPS TTM	-3.07	-2.68	-3.05	-2.91	-2.47	-2.49	-2.88	-2.43	-2.65	-2.64	-2.65	-2.73
Free Cash Flow Per Share TTM	-2.74	-2.47	-3.04	-2.87	-2.69	-2.41	-2.71	-1.47	-1.70	-1.53	-1.65	-2.84
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-982.37%	-439.26%	-340.16%	-319.32%	-260.75%	-408.87%	-390.52%	-343.30%	-287.47%	-194.51%	-201.41%	-230.89%
Net Profit Margin TTM	-928.44%	-411.37%	-314.90%	-292.50%	-234.58%	-369.40%	-354.85%	-313.65%	-264.84%	-178.93%	-186.98%	-216.74%
Growth Metrics
Net Revenue Growth (1Y)	-58.40%	27.23%	53.95%	48.32%	41.86%	-30.25%	-29.15%	-17.76%	2.25%	94.02%	99.31%	74.85%
Net Income Growth (1Y)	64.65%	41.69%	36.62%	38.32%	25.65%	43.99%	34.47%	19.01%	4.81%	-18.94%	-20.19%	-13.21%
EPS Growth (1Y)	24.33%	7.56%	5.81%	19.61%	-6.57%	-5.39%	8.86%	-11.06%	-8.83%	-20.24%	-28.60%	-18.83%
Valuation Metrics
P/E TTM	-5.78	-5.95	-5.79	-3.21	-4.30	-6.19	-7.67	-10.36	-5.95	-4.68	-2.35	-3.11
P/B TTM	4.90	3.66	2.84	2.11	1.99	2.68	2.82	4.87	2.65	4.02	1.69	1.98
P/S TTM	53.66	24.49	18.25	9.39	10.09	22.88	27.21	32.50	15.77	8.38	4.39	6.74
Market Cap	1.97B	1.76B	1.53B	786.05M	891.67M	1.29B	1.48B	1.83B	982.45M	678.06M	337.98M	462.32M
Enterprise Value	1.90B	1.69B	1.53B	706.64M	807.41M	1.21B	1.37B	1.73B	864.76M	627.34M	283.35M	420.02M
Calculated Values
Free Cash Flow TTM	-304.53M	-271.85M	-263.47M	-241.36M	-225.79M	-201.59M	-181.86M	-106.90M	-105.97M	-83.87M	-89.77M	-154.39M
Net Debt	-68.65M	-71.20M	-6.48M	-79.41M	-84.26M	-76.82M	-110.00M	-99.95M	-117.69M	-50.71M	-54.63M	-42.30M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-25Sale

Owner: Hansen, Gwenn

Title: Chief Scientific Officer

Shares: 5,394

Price/Share: $20.00

Value: $107,880.00

Shares Owned: 115,005

Relationship: Officer

Ownership: Direct

2026-06-25Sale

Owner: Ring, Christine

Title: Chief Legal Officer

Shares: 28,935

Price/Share: $20.06

Value: $580,436.10

Shares Owned: 13,579

Relationship: Officer

Ownership: Direct

2026-06-02Sale

Owner: Ring, Christine

Title: Chief Legal Officer

Shares: 8,148

Price/Share: $16.60

Value: $135,256.80

Shares Owned: 13,579

Relationship: Officer

Ownership: Direct

2026-05-05Sale

Owner: Van, Houte Hans

Title: Chief Financial Officer

Shares: 14,055

Price/Share: $16.88

Value: $237,248.40

Shares Owned: 37,592

Relationship: Officer

Ownership: Direct

2026-05-04Sale

Owner: Ring, Christine

Title: Chief Legal Officer

Shares: 8,148

Price/Share: $16.96

Value: $138,190.08

Shares Owned: 18,305

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-25	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	5,394	20.00	$107,880.00	115,005	4
2026-06-25	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	28,935	20.06	$580,436.10	13,579	4
2026-06-02	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	8,148	16.60	$135,256.80	13,579	4
2026-05-05	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	14,055	16.88	$237,248.40	37,592	4
2026-05-04	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	8,148	16.96	$138,190.08	18,305	4
2026-05-01	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	5,394	16.76	$90,403.44	26,453	4
2026-04-30	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	2,388	16.65	$39,760.20	51,647	4
2026-04-30	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	3,214	16.65	$53,513.10	120,399	4
2026-04-30	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	3,214	16.65	$53,513.10	31,847	4
2026-04-02	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	8,148	15.24	$124,175.52	26,453	4
2026-03-02	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	8,148	15.44	$125,805.12	34,601	4
2026-02-09	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	14,261	16.66	$237,588.26	42,749	4
2026-01-30	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	3,661	16.98	$62,163.78	45,427	4
2026-01-30	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	4,895	16.98	$83,117.10	83,672	4
2026-01-30	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	4,421	16.98	$75,068.58	57,010	4
2026-01-20	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	3,760	18.42	$69,259.20	50,897	4
2025-12-18	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	3,760	18.22	$68,507.20	50,897	4
2025-11-24	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	37,600	17.07	$641,832.00	50,897	4
2025-11-03	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	6,284	12.56	$78,927.04	37,592	4
2025-10-30	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	4,087	12.80	$52,313.60	76,751	4
2025-10-30	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	3,644	12.80	$46,643.20	50,897	4
2025-10-30	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	3,130	12.80	$40,064.00	43,876	4
2025-08-01	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	5,402	11.03	$59,584.06	35,512	4
2025-07-30	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	4,308	12.01	$51,739.08	69,023	4
2025-07-30	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	4,304	12.01	$51,691.04	40,914	4
2025-07-30	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	3,841	12.01	$46,130.41	44,009	4
2025-05-02	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	6,198	11.33	$70,223.34	33,724	4
2025-04-30	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	2,438	11.50	$28,037.00	39,922	4
2025-04-30	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	3,377	11.50	$38,835.50	61,516	4
2025-04-30	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	2,894	11.50	$33,281.00	37,318	4
2025-03-03	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	5,825	14.76	$85,977.00	33,724	4
2025-01-31	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	5,760	20.21	$116,409.60	32,538	4
2025-01-30	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	3,690	20.07	$74,058.30	55,937	4
2025-01-30	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	2,811	20.07	$56,416.77	39,549	4
2025-01-30	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	3,220	20.07	$64,625.40	32,538	4
2025-01-02	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	5,760	19.50	$112,320.00	28,084	4
2024-12-02	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	5,760	21.73	$125,164.80	28,084	4
2024-11-04	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	3,290	25.00	$82,250.00	28,084	4
2024-11-01	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	3,546	24.28	$86,096.88	33,724	4
2024-11-01	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	5,760	24.28	$139,852.80	28,084	4
2024-10-30	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	3,437	24.31	$83,553.47	50,670	4
2024-10-30	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	4,182	24.31	$101,664.42	28,084	4
2024-10-30	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	2,368	24.31	$57,566.08	37,270	4
2024-10-14	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	3,290	25.00	$82,250.00	24,592	4
2024-10-01	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	5,760	22.50	$129,600.00	24,592	4
2024-09-03	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	9,050	25.28	$228,784.00	24,592	4
2024-08-26	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	9,870	25.01	$246,848.70	24,592	4
2024-08-26	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	20,000	25.22	$504,400.00	31,002	4
2024-08-01	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	5,760	21.78	$125,452.80	24,592	4
2024-08-01	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	3,477	21.82	$75,868.14	51,002	4
2024-07-30	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	3,408	20.67	$70,443.36	45,150	4
2024-07-30	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	2,490	20.67	$51,468.30	54,479	4
2024-07-30	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	2,920	20.67	$60,356.40	24,592	4
2024-07-01	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	5,760	21.12	$121,651.20	19,838	4
2024-06-20	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	20,000	20.01	$400,200.00	48,333	4
2024-06-13	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	1,864	17.02	$31,725.28	19,838	4
2024-06-12	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	1,900	17.01	$32,319.00	19,838	4
2024-06-05	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	400	17.00	$6,800.00	19,838	4
2024-06-03	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	1,596	17.01	$27,147.96	19,838	4
2024-05-02	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	3,499	12.83	$44,892.17	68,333	4
2024-04-30	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	2,007	12.04	$24,164.28	39,601	4
2024-04-30	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	1,387	12.04	$16,699.48	71,832	4
2024-04-30	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	1,513	12.04	$18,216.52	19,838	4
2024-02-16	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	6,812	10.02	$68,256.24	68,333	4
2024-01-30	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	1,760	7.99	$14,062.40	17,427	4
2024-01-30	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	2,334	7.99	$18,648.66	36,402	4
2024-01-30	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	1,671	7.99	$13,351.29	75,145	4
2023-12-20	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	3,541	10.00	$35,410.00	71,930	4
2023-12-19	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	10,906	10.00	$109,060.00	75,471	4
2023-10-31	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	1,080	5.20	$5,616.00	86,377	4
2023-10-31	Ring, Christine	Officer	Chief Legal Officer	Direct	Sale	1,232	5.20	$6,406.40	15,263	4
2023-10-31	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	1,633	5.20	$8,491.60	33,529	4
2023-07-31	Hansen, Gwenn	Officer	Chief Scientific Officer	Direct	Sale	1,884	9.65	$18,180.60	29,955	4
2023-07-31	Ring, Christine	Officer	General Counsel	Direct	Sale	1,420	9.65	$13,703.00	12,544	4
2023-07-31	Van, Houte Hans	Officer	Chief Financial Officer	Direct	Sale	1,245	9.65	$12,014.25	82,571	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

102.27%

Inst. Shares: 112,575,301

Shares Outstanding: 110,071,668

2025-12-31

125.63%

Inst. Shares: 108,875,613

Shares Outstanding: 86,666,907

2025-09-30

96.20%

Inst. Shares: 80,959,207

Shares Outstanding: 84,159,336

2025-06-30

97.14%

Inst. Shares: 81,486,615

Shares Outstanding: 83,882,477

2025-03-31

94.15%

Inst. Shares: 78,672,872

Shares Outstanding: 83,560,795

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	112,575,301	110,071,668	102.27%
2025-12-31	108,875,613	86,666,907	125.63%
2025-09-30	80,959,207	84,159,336	96.20%
2025-06-30	81,486,615	83,882,477	97.14%
2025-03-31	78,672,872	83,560,795	94.15%
2024-12-31	74,634,716	67,120,266	111.20%
2024-09-30	60,851,542	72,779,381	83.61%
2024-06-30	58,751,198	62,377,551	94.19%
2024-03-31	45,154,305	54,903,407	82.24%
2023-12-31	42,350,300	54,337,901	77.94%
2023-09-30	41,490,521	54,390,859	76.28%
2023-06-30	38,878,899	54,259,045	71.65%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Nurix Therapeutics, Inc. (NRIX) — SEC Financial Statements & Analysis

Nurix Therapeutics, Inc. (NRIX) is a pharmaceutical preparations company, incorporated in DE. Nurix Therapeutics, Inc. trades on Nasdaq as: NRIX. Based on its latest SEC filing (Form 10-Q, period ending 2026-05-31), Nurix Therapeutics, Inc. reported a -58.40% year-over-year revenue growth, a Debt-to-Equity ratio of 0.33x, a Price-to-Sales (P/S) ratio of 53.66x (TTM), a Price-to-Book (P/B) ratio of 4.90x (TTM), at a market cap of $1.97B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -58.40%
Debt To Equity: 0.33x
P/S TTM: 53.66x
P/B TTM: 4.90x
Market Cap: $1.97B

Data as of 2026-05-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Nurix Therapeutics, Inc. in?

Nurix Therapeutics, Inc. (NRIX) operates in the Pharmaceutical Preparations industry.

What is NRIX's market cap?

Nurix Therapeutics, Inc. (NRIX) has a market capitalization of $1.97B as of 2026-05-31.

What exchange does NRIX trade on?

Nurix Therapeutics, Inc. (NRIX) trades on the Nasdaq.

Where is Nurix Therapeutics, Inc. incorporated?

Nurix Therapeutics, Inc. is incorporated in DE.